LS&HC Horizons 2022 - Flipbook - Page 4
1
Precision and
Regenerative Medicine
CTGT transactions: Beware the ripples in the safe harbor
5
The rising complexities of harnessing genomic data
6
Gene and cell therapeutics and advanced therapy
medicinal products (ATMP) in Europe
7
Potential liability risks associated with administration of
gene therapies and ATMPs in Europe
8
Product sameness in an increasingly complex environment:
Considerations for cellular and gene therapy products
9
